Amgen's Bone Drug Xgeva Delays Pain From Prostate Cancer Metastases
This article was originally published in The Pink Sheet Daily
Executive Summary
Some physicians may be concerned by the incidence of osteonecrosis of the jaw reported in pivotal hormone-resistant prostate cancer trial.